Healthcare
Sunniva Inc.(SNNVF)
Live Price
Offline$0.0001
+0.00% today
1Y Change
+900.00%
Window
Jun 20, 2025 โ Jun 17, 2026
- Market Cap
- $10.00M
- Revenue Growth
- +16.9%
- EPS Growth
- -51.7%
- Dividend Yield
- 0.0%
Coverage: 250 bars ยท Jun 20, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sunniva Inc. (SNNVF) is a Healthcare stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.00 and up 900.0% across the available one-year price window (Jun 20, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of +16.9%, EPS growth of -51.7%, a dividend yield of 0.0%. What stands out right now is revenue +16.9%, EPS -51.7%, free cash flow -270.9% with operating margin -149.7% and ROIC -25.4%. Valuation is more restrained than many high-expectation growth names at price/sales 0.3. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SNNVF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+16.9% vs +7.6% peer median
Operating Margin
Below sector median
-149.7% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2024 was reported on Aug 30, 2024, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +16.9% and EPS is at -51.7%, with operating margin around -149.7%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2024 Aug 30, 2024 | โ | +0.0% | +0.0% | +0.0% |
2024 May 31, 2024 | โ | +0.0% | +0.0% | +0.0% |
2024 Feb 28, 2024 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SNNVF
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SNNVF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SNNVF and SPY.
Company Overview
Sunniva Inc.
Other OTC
Sunniva Inc., a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States. The company operates through Patient Counselling, Merchandising, and Cultivation & Extraction segments. It offers its products under the Sun Fire, Kyndness, and Herbella brands. The company was formerly known as Sunniva Holdings Corp. and changed its name to Sunniva Inc. in August 2017. Sunniva Inc. was founded in 2014 and is headquartered in Vancouver, Canada.
- Leadership
- Anthony F. Holler
- IPO Date
- Jan 11, 2018
- Employees
- 148
- Street Address
- 1200 Waterfront Centre
- Mailing
- Vancouver, BC, V6C 3L6
- Region
- Vancouver, BC, CA
- Reporting Currency
- USD
- Investor Line
- 866 786 6482
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.3
- Price/Book
- 0.1
Growth
- Revenue
- +16.9%
- EPS
- -51.7%
- Free Cash Flow
- -270.9%
Profitability
- Gross Margin
- 41.5%
- Operating Margin
- -149.7%
- Net Margin
- -154.6%
- ROE
- -48.7%
- ROIC
- -25.4%
Balance Sheet
- Debt/Equity
- 0.28
- Current Ratio
- 0.93
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.